Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model

  • The PLOS ONE Staff

Fig 1B and 1C, “The evaluation of the CAFs marker on each treatment day.” does not appear. Please view Fig 1 here.

thumbnail
Fig 1. The evaluation of the CAFs marker on each treatment day.

(A) qRT-PCR analysis. The mRNA expression was evaluated weekly and at the endpoint. The expression of all the markers increased significantly over time *p < 0.05). (B) Immunohistochemical staining. All images were recorded at 200×magnification. (C) Immunohistochemical Evaluation. The IRS scores for all markers significantly increased over time *p < 0.05).

https://doi.org/10.1371/journal.pone.0307334.g001

Fig 3B and 3C, “The effect of transcutaneous CO2 treatment.” does not appear. Please view Fig 3 here.

thumbnail
Fig 3. The effect of transcutaneous CO2 treatment.

(A) qRT-PCR analysis. The expression of each marker was evaluated on Day 25. Compared with the control group, the expression of α-SMA, FAP, PDPN, and TGF-β was significantly suppressed in the CO2-treated group. *p < 0.05. (B) Immunohistochemical staining (magnification: 200×). (C) Immunohistochemical evaluation. The IRS score of all markers was significantly suppressed in the CO2-treated group. *p < 0.05.

https://doi.org/10.1371/journal.pone.0307334.g002

The publisher apologizes for the errors.

Reference

  1. 1. Tadokoro Y, Takeda D, Murakami A, Yatagai N, Saito I, Arimoto S, et al. (2023) Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model. PLoS ONE 18(8): e0290357. https://doi.org/10.1371/journal.pone.0290357 pmid:37594996